LifeTech Research

LifeTech Research, Inc. is a Maryland-based technology research and venture development firm specializing in the commercialization of early-stage life science innovations. Founded in 2003, the company provides strategic advisory services, including investment due diligence and business development, to financial institutions and emerging biotech companies. LifeTech Research is most notable for co-founding C2N Diagnostics in partnership with researchers from Washington University in St. Louis, which has developed breakthrough blood-based biomarkers and therapeutic antibodies for Alzheimer's disease. The firm's portfolio includes several other medical technology startups where it leverages its expertise in regulatory affairs and clinical development to drive product success. By bridging the gap between academic research and the marketplace, LifeTech Research facilitates the advancement of disruptive healthcare technologies.